vs

Side-by-side financial comparison of Civeo Corp (CVEO) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

OMNICELL, INC. is the larger business by last-quarter revenue ($309.9M vs $161.6M, roughly 1.9× Civeo Corp). OMNICELL, INC. runs the higher net margin — 3.7% vs -4.0%, a 7.7% gap on every dollar of revenue. On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs 7.1%). OMNICELL, INC. produced more free cash flow last quarter ($38.6M vs $14.5M). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs -1.4%).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

CVEO vs OMCL — Head-to-Head

Bigger by revenue
OMCL
OMCL
1.9× larger
OMCL
$309.9M
$161.6M
CVEO
Growing faster (revenue YoY)
OMCL
OMCL
+7.8% gap
OMCL
14.9%
7.1%
CVEO
Higher net margin
OMCL
OMCL
7.7% more per $
OMCL
3.7%
-4.0%
CVEO
More free cash flow
OMCL
OMCL
$24.2M more FCF
OMCL
$38.6M
$14.5M
CVEO
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
-1.4%
CVEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVEO
CVEO
OMCL
OMCL
Revenue
$161.6M
$309.9M
Net Profit
$-6.5M
$11.4M
Gross Margin
22.7%
45.3%
Operating Margin
-0.1%
60.1%
Net Margin
-4.0%
3.7%
Revenue YoY
7.1%
14.9%
Net Profit YoY
58.1%
EPS (diluted)
$-0.58
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$161.6M
$314.0M
Q3 25
$170.5M
$310.6M
Q2 25
$162.7M
$290.6M
Q1 25
$144.0M
$269.7M
Q4 24
$151.0M
$306.9M
Q3 24
$176.3M
$282.4M
Q2 24
$188.7M
$276.8M
Net Profit
CVEO
CVEO
OMCL
OMCL
Q1 26
$11.4M
Q4 25
$-6.5M
Q3 25
$-455.0K
$5.5M
Q2 25
$-3.3M
$5.6M
Q1 25
$-9.8M
$-7.0M
Q4 24
$-15.4M
Q3 24
$-5.1M
$8.6M
Q2 24
$8.2M
$3.7M
Gross Margin
CVEO
CVEO
OMCL
OMCL
Q1 26
45.3%
Q4 25
22.7%
41.5%
Q3 25
25.7%
43.3%
Q2 25
25.3%
43.9%
Q1 25
20.4%
41.1%
Q4 24
18.6%
46.2%
Q3 24
21.4%
43.3%
Q2 24
25.4%
41.3%
Operating Margin
CVEO
CVEO
OMCL
OMCL
Q1 26
60.1%
Q4 25
-0.1%
0.1%
Q3 25
4.1%
2.7%
Q2 25
1.7%
2.8%
Q1 25
-3.8%
-4.3%
Q4 24
-6.7%
4.0%
Q3 24
0.0%
2.3%
Q2 24
6.9%
1.2%
Net Margin
CVEO
CVEO
OMCL
OMCL
Q1 26
3.7%
Q4 25
-4.0%
Q3 25
-0.3%
1.8%
Q2 25
-2.0%
1.9%
Q1 25
-6.8%
-2.6%
Q4 24
-10.2%
Q3 24
-2.9%
3.1%
Q2 24
4.4%
1.3%
EPS (diluted)
CVEO
CVEO
OMCL
OMCL
Q1 26
$0.25
Q4 25
$-0.58
$-0.05
Q3 25
$-0.04
$0.12
Q2 25
$-0.25
$0.12
Q1 25
$-0.72
$-0.15
Q4 24
$-1.04
$0.34
Q3 24
$-0.36
$0.19
Q2 24
$0.56
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$14.4M
$239.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.4M
$1.3B
Total Assets
$477.4M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$14.4M
$196.5M
Q3 25
$12.0M
$180.1M
Q2 25
$14.6M
$399.0M
Q1 25
$28.4M
$386.8M
Q4 24
$5.2M
$369.2M
Q3 24
$17.9M
$570.6M
Q2 24
$7.4M
$556.8M
Total Debt
CVEO
CVEO
OMCL
OMCL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$43.3M
Q3 24
Q2 24
Stockholders' Equity
CVEO
CVEO
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$174.4M
$1.2B
Q3 25
$182.5M
$1.2B
Q2 25
$209.4M
$1.3B
Q1 25
$220.7M
$1.3B
Q4 24
$236.4M
$1.2B
Q3 24
$282.2M
$1.2B
Q2 24
$297.4M
$1.2B
Total Assets
CVEO
CVEO
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$477.4M
$2.0B
Q3 25
$491.1M
$1.9B
Q2 25
$508.8M
$2.1B
Q1 25
$423.8M
$2.2B
Q4 24
$405.1M
$2.1B
Q3 24
$477.6M
$2.3B
Q2 24
$483.2M
$2.3B
Debt / Equity
CVEO
CVEO
OMCL
OMCL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
OMCL
OMCL
Operating Cash FlowLast quarter
$19.3M
$54.5M
Free Cash FlowOCF − Capex
$14.5M
$38.6M
FCF MarginFCF / Revenue
8.9%
12.5%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$2.1M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$19.3M
$30.4M
Q3 25
$13.8M
$28.3M
Q2 25
$-2.3M
$42.8M
Q1 25
$-8.4M
$25.9M
Q4 24
$9.5M
$56.3M
Q3 24
$35.7M
$22.8M
Q2 24
$32.4M
$58.7M
Free Cash Flow
CVEO
CVEO
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$14.5M
$22.6M
Q3 25
$8.2M
$18.5M
Q2 25
$-6.8M
$31.0M
Q1 25
$-13.7M
$14.8M
Q4 24
$1.8M
$47.2M
Q3 24
$28.2M
$13.9M
Q2 24
$27.0M
$49.1M
FCF Margin
CVEO
CVEO
OMCL
OMCL
Q1 26
12.5%
Q4 25
8.9%
7.2%
Q3 25
4.8%
6.0%
Q2 25
-4.2%
10.7%
Q1 25
-9.5%
5.5%
Q4 24
1.2%
15.4%
Q3 24
16.0%
4.9%
Q2 24
14.3%
17.8%
Capex Intensity
CVEO
CVEO
OMCL
OMCL
Q1 26
Q4 25
3.0%
2.5%
Q3 25
3.3%
3.1%
Q2 25
2.8%
4.1%
Q1 25
3.7%
4.1%
Q4 24
5.1%
3.0%
Q3 24
4.2%
3.1%
Q2 24
2.8%
3.5%
Cash Conversion
CVEO
CVEO
OMCL
OMCL
Q1 26
4.80×
Q4 25
Q3 25
5.18×
Q2 25
7.58×
Q1 25
Q4 24
Q3 24
2.64×
Q2 24
3.93×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVEO
CVEO

Segment breakdown not available.

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons